Navigation Links
U.S. Air Force Pays Record Amount for Baby Injured in Government Hospital
Date:5/9/2008

WASHINGTON, May 9 /PRNewswire/ -- The U.S. Air Force has paid a family $5 million for severe brain damage suffered by a baby during childbirth at a military hospital. The amount is a record sum for government settlement payments to children who suffered brain damage because of the negligence of government employees, according to what Air Force attorneys told the family's attorneys.

Aubrey Duckworth was born on September 4, 2004 at the U.S. Naval Hospital, Okinawa, Japan. Her mother's uterus ruptured during the birthing process, depriving the baby of oxygen for a prolonged time. Aubrey suffers from spastic cerebral palsy and blindness. She is fed through a surgical tube implanted in her stomach.

Most of the settlement money will go into a trust to pay Aubrey's medical and nursing bills, which are expected to be high because she needs round-the-clock nursing attention.

Aubrey's parents, Lindsey and William Duckworth, brought a claim under the Military Claims Act alleging that the nurse midwife, Laura A. Bennett, who attended Lindsey's labor and delivery was grossly negligent and guilty of malpractice for trying to manage a complex and high-risk delivery by herself without calling in an obstetrician. Mrs. Duckworth had previously had a cesarean section for her first baby, and Aubrey's birth was set up as a "VBAC" -- vaginal birth after cesarean. According to independent obstetrician experts who reviewed the childbirth records, Nurse Bennett, in response to the baby's failure to descend in the birth canal, repeatedly increased the dosage of a drug to stimulate uterine contractions -- Pitocin or oxytocin -- despite warning signs that the uterus was overly stimulated. The uterus eventually ruptured, cutting off oxygen to the fetus through the placenta. Nurse Bennett called an obstetrician to the scene only after the uterus ruptured. Aubrey then was delivered by an emergency cesarean section, but it was too late to prevent her brain injury.


'/>"/>
SOURCE Patrick Malone & Associates, P.C.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Employee Engagement & Retention: Benchmarking Metrics and Networking Opportunity to Help Solve Todays Workforce Challenges
2. Medical Mutual of Ohio, CareWorks Build a Healthier Workforce
3. Strike Force Targets Medicare Fraud By Los Angeles Area Health Care Companies
4. Best Practice Database: Complimentary Excerpt of Three Sales Force Excellence Studies
5. Pilot study reinforces use of portable anteroom HEPA filtration
6. The American College of Cardiology Foundations NCDR(R) and the American Heart Associations GWTG Join Forces to Fight Heart Attacks
7. Stronger-Than-Ever Generic Threat Forces Big Pharma to Be Creative
8. Best Practice Database Adds New Research on Effective Sales Force Incentives and Continuing Medical Education
9. Ferring Pharmaceuticals EUFLEXXA(TM) to Serve as Sponsor for Sprint Force America Masters Track Club
10. UVA Health System part of Armed Forces multi-million dollar effort to help soldiers
11. Baby boomer health care crisis looms; GSA bolsters call for stronger workforce
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)..., May 13 /PRNewswire/ -- BIOCOM, the association f... has expanded its BIOCOM,Purchasing Group contract...re, Innovative Lease Services, NexAira and Worldwi...dors who discount their goods and services,for BIO...ovide BIOCOM members with special,rates on press r...
(Date:5/13/2008)...N, Fla., May 13 /PRNewswire-FirstCall/ -- The Quan...ubsidiary, Renaissance Health System,of Florida, I... HMO,partners in South Florida to include the use ...tionship will allow Renaissance to extend medical,...will initially cover,South Florida, which has over...
(Date:5/13/2008)... Calif., May 13 /PRNewswire/ -- TorreyPines Therap...inancial results and accomplishments for,the first... period, the,company posted revenue of $2.0 millio...uivalents totaled $25.7 million at March 31, 2008....egic plan outlined in,February, maximizing the val...
(Date:5/13/2008)... Toronto Stock Exchange Symbol: DND, MISSI... Pharmaceuticals,Inc. (TSX: DND) today announced t...submitted to the U.S. Food and Drug Administration...ormulation of tramadol. In May 2007,the Company r...ng to its,NDA for CIP-TRAMADOL ER., Cipher,s revi...
Breaking Medicine News(10 mins):Health News:BIOCOM Purchasing Group Brings in Four New Contracts 2Health News:BIOCOM Purchasing Group Brings in Four New Contracts 3Health News:BIOCOM Purchasing Group Brings in Four New Contracts 4Health News:The Quantum Group Executes First Medicaid Service Contract with HMO 2Health News:The Quantum Group Executes First Medicaid Service Contract with HMO 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 2Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 3Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 4Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 5Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 6Health News:TorreyPines Therapeutics Reports First Quarter 2008 Financial Results and Accomplishments 7Health News:Cipher provides regulatory update for CIP-TRAMADOL ER 2Health News:Cipher provides regulatory update for CIP-TRAMADOL ER 3
...ltinational team of researchers based in the UK ha...s biological barriers, opening up the potential fo...rchers from the School of Pharmacy, University of ...otubes by adding a range of different functional g...
...U.S. Food and Drug Administration (FDA) today clea... device that can help save the arms and legs of so...ndividuals in other trauma settings and emergency ... Limb Salvage Shunt (TLSS), made by Vascutek Ltd. ...
...a's drug major Ranbaxy Laboratories has received t...pproval to manufacture// and market its formulatio...in adults. Ranbaxy Pharmaceuticals Inc. (RPI), a ...oratories Limited (RLL), announced Friday that FDA...
...he recent years, scientists discovered a family of...xtend life in organisms// as diverse as yeast, wor...t The Wistar Institute points to another strategy ...ir anti-aging powers. They may also be able to con...
Other Medicine News:Health News:Carbon Nanoneedles For Drug Delivery 2Health News:Carbon Nanoneedles For Drug Delivery 3Health News:Carbon Nanoneedles For Drug Delivery 4Health News:FDA Clears Critical Limb-Saving Vascular Device 2Health News:Anti-Aging Powers of Enzyme Sirtuins 2
(Date:5/12/2008)...Patients in Cohort 3 Demonstrated Improvement in T...rapeutic Potential of HspE7, SAN DIEGO, May 12 /P...Corporation (TSX: NVN) today announced positive im...ing Phase 1 clinical trial of its lead product,can...helial neoplasia, or,CIN, a precursor to cervical ...
(Date:5/9/2008)...A, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoart...ondition that affects almost 50,million people in ...f,cartilage in bone joints. The novel investigatio... oral analgesic, provided significant relief,for p... treated with,placebo, and with fewer gastrointest...
(Date:5/9/2008)...TTLE, May 9 /PRNewswire-USNewswire/ -- The risk of...n prostatic hyperplasia (BPH), can be,reduced by c...ntaining a,normal weight and eating a healthy diet...cer Prevention Program at Fred Hutchinson Cancer R...ies that suggest men need not,feel helpless agains...
(Date:5/9/2008)...th International Phase III Study Shows Positive Re...ata -, NUTLEY, N.J., May 9 /- Roche ...ar Phase III study showing that ACTEMRA(TM),(tocil...tructural damage to,joints in patients with rheuma...veness of an RA treatment. The study also demonstr...
Breaking Medicine Technology:Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 2Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 3Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 4Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 5Nventa Announces Additional Positive Immunological Data From HspE7 Phase 1 Cervical Dysplasia Trial 6Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 2Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 3Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Men's Health Week Is June 9-15) 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 2New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 3New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 4New Study Demonstrates ACTEMRA(R) (tocilizumab) Inhibits Progression of Joint Damage in Rheumatoid Arthritis Patients 5Memory in artificial atoms 4445 1Memory in artificial atoms 4445 2Faster Test Detects Fake Tamiflu Drugs 16192 1Faster Test Detects Fake Tamiflu Drugs 16192 2Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 16187 1Chehalis Tribes Announce Benefit to Help Returning Combat Veterans 16187 2Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 1Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 2Genaera Corporation Receives Audit Opinion Containing Going Concern Explanatory Paragraph 16183 3
... Vaginal Supplement Studied in Largest-Ever IVF Tr...PRNewswire/ -- Results of,four studies evaluating ...ogesterone vaginal insert in development for lutea...t for implantation and,the early stages of pregnan...re presented at the 55th Annual Meeting of the,Pac...
... N.J., April 18, 2007 /PRNewswire-FirstCall/ --,ON...rug candidate,may have potential as a chemopreven...ma researcher Michele Carbone M.D., Ph.D.,at this...AACR),Annual Meeting. , In a series of poster pres...ldwide problem of asbestos exposure and its link t...
Other Medicine Technology:Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 2Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 3Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 4Ferring Reports on ENDOMETRIN Presentations at Pacific Coast,Reproductive Society Annual Meeting 5Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 2Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 3Onconase has Potential as Chemopreventive Agent in Mesothelioma,Reports World-Renowned Mesothelioma Researcher at AACR Annual,Meeting 4
Blunt, with attached cable for Valleylab and other brands generators.
Blunt, 20 cm long.
Angulated, blunt tips.
All Bovie LLETZ Loop and Square electrodes feature tungsten wire for superior shape and integrity throughout the excision procedure. They use a standard 3/32" (2.3 mm) shaft. All molded loops are pac
Medicine Products: